Trials / Active Not Recruiting
Active Not RecruitingNCT06142825
Developing, Implementing and Evaluating Effective Community-facility Interactions to Improve Blood Availability and Transfusion in Three Distinct County Settings in Kenya
Developing, Implementing and Evaluating Effective Community-facility Interactions to Improve Blood Availability and Transfusion in Three Distinct County Settings in Kenya (CoBAnK): A Type III Hybrid Effectiveness-implementation Trial.
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 9 (estimated)
- Sponsor
- University of Minnesota · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
The strategy of the CoBAnK study is to establish and enable the function of Community-Facility Transfusion Committees (CFTCs) incorporating diverse representation involving hospital, community, and county leadership, to improve blood availability and transfusion at the point-of-care.
Detailed description
The strategy of the CoBAnK study is to establish and enable the function of Community-Facility Transfusion Committees (CFTCs) incorporating diverse representation involving hospital, community, and county leadership, to improve blood availability and transfusion at the point-of-care. The CFTC strategy will be evaluated across nine transfusing facilities across three counties in Kenya (two intervention and one control site in each county). While the intervention will be tested in "beta" facilities (i.e., facilities without a co-located blood bank) in each county, blood availability will also be measured in "alpha" facilities (i.e., facilities with co-located blood banks) in the three counties, which supply blood to the beta facilities.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Community-Facility Transfusion Committee (CFTC) | Community-Facility Transfusion Committees (CFTCs) are intended to incorporate diverse representation involving hospital, community, and county leadership, to improve blood availability and transfusion at the point-of-care. |
Timeline
- Start date
- 2025-03-11
- Primary completion
- 2026-06-11
- Completion
- 2026-06-11
- First posted
- 2023-11-22
- Last updated
- 2026-04-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06142825. Inclusion in this directory is not an endorsement.